Clinical Trial Update: N-Acetylcysteine in Patients With Sickle Cell Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of N-acetylcysteine in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Sickle Cell Disease | Phase 3 | Status: COMPLETED